Senior Research Associate, Biology

Senior/Principal Research Associate Research, Mass Spectrometry and Proteomics

Senior Scientist/Principal/Senior Principal Scientist,  Cheminformatics/ML

Director/ Senior Director, Scientific Computing & Informatics

Scientist I/II, Mass Spectrometry and Proteomics

Don't see an opening for you? Apply anyways!

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

A-Alpha Bio

A2 Biotherapeutics

AAVogen

ACELYRIN

AI Proteins

AIRNA Bio

ALX Oncology

AN2 Therapeutics

AOA Dx

ARTBIO

AUM BioTech

AVROBIO

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

Acepodia

Achieve Life Sciences

Acomhal Research

Acrivon Therapeutics

Actym Therapeutics, Inc.

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

Admera Health

Adverum Biotechnologies

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agastiya Biotech

Agena Bioscience

AiViva Biopharma

Ainnocence

AivoCode

Aixa Bio

Akero Therapeutics

Akita Biosciences

Akouos

Alamar Biosciences

Alector

Alida Biosciences

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Oncology

Alphabioregen

Alpine Immune Sciences

AltPep

Alterome Therapeutics

Altis Biosystems

Alto Neuroscience

Alumis

Alveo Technologies

Alveolus Bio

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AnHeart Therapeutics

Anagram Therapeutics

Ancora Biotech LLC

Andes

Andson Biotech

Anebulo Pharmaceuticals

Angiex

Angiocrine Bioscience

Anima Biotech

Ankyra

Annexon Biosciences

Anodyne Nanotech

Anokion

Ansa Biotechnologies

Antheia

Anthos Therapeutics

Apaxon Biotech LLC

Flare Therapeutics is targeting transcription factors to identify therapeutics for cancer treatment. Transcription factors (TFs) bind DNA and control gene expression, which dictates the functional output of a cell. Due to their importance, mutations in TFs are common causes of cancer, yet this protein class has remained elusive for drug discovery. Flare is changing this by designing small molecules that target the switch site of TFs to regain transcriptional control. Switch sites reflect the cooperative nature of TF domains and offer a new druggable pocket to control activity. With this information, Flare is developing a differentiated pipeline of drug programs to target the central genetic drivers of cancer and other diseases.

<p>Flare Therapeutics is targeting transcription factors to identify therapeutics for cancer treatment. Transcription factors (TFs) bind DNA and control gene expression, which dictates the functional output of a cell. Due to their importance, mutations in TFs are common causes of cancer, yet this protein class has remained elusive for drug discovery. Flare is changing this by designing small molecules that target the switch site of TFs to regain transcriptional control. Switch sites reflect the cooperative nature of TF domains and offer a new druggable pocket to control activity. With this information, Flare is developing a differentiated pipeline of drug programs to target the central genetic drivers of cancer and other diseases.</p>


Find a biotech startup job.